Get started
Author

Débora Guilherme de Albuquerque e Rodrigues de Sousa

Observed names: Barbosa Pereira de Sousa, Daví, Daví Barbosa Pereira de Sousa, Debora G. Sousa, Debora Guilherme De Albuquereque E Rodrigues De Sousa, Debora Guilherme de Alburquerque E Rodrigues de Sousa
ORCID: 0009-0006-5228-6946
Observed ORCID: 0009-0006-5228-6946
OpenAlex ID: A5111219895
Bevacizumab rechallenge in platinum-resistant ovarian cancer: Evidence from a propensity score–matched analysis.
2026 · Celso Silva Sousa Filho, Lurick Rodrigues Soares, et al. · Journal of Clinical Oncology · 1
Real life comparison between doxorubicin and cyclophosphamide (AC) dose-dense (dd) and conventional dose AC in patients with triple negative breast cancer (TNBC) under neoadjuvant treatment.
2024 · Flavia Cavalcanti Balint, Monique Celeste Tavares, et al. · Journal of Clinical Oncology · 1
Tendência temporal e distribuição espacial da mortalidade por diabetes mellitus tipo 1 em Minas Gerais, Brasil, 2018–2023
2026 · Samira de Souza Guiçardes Brêtas, Daví Barbosa Pereira de Sousa, et al. · Journal of Health & Biological Sciences
PDF
Real-World Effectiveness and Safety of Adjuvant Abemaciclib Plus Endocrine Therapy in Brazilian Patients with High-Risk Hormone Receptor-positive, HER2-Negative Early Breast Cancer
2026 · Carolina Pereira dos Santos, Monique Celeste Tavares, et al. · Brazilian Journal of Oncology
Functional domain disruption to define the molecular and clinical spectrum of germline RAD51 family variants in hereditary breast cancer (BC).
2026 · André Luiz Cicilini, Sandrine Caputo, et al. · Journal of Clinical Oncology
Tendência temporal e distribuição espacial dos óbitos por doenças respiratórias infecciosas na população indígena: análise espacial e de séries temporais, Minas Gerais, 2000-2023
2025 · Silva Siqueira, Paulo Filipe, Barbosa Pereira de Sousa, Daví, et al. · SciELO - Scientific Electronic Library Online Dataverse
Abstract P5-09-18: Real-World Analysis of Patients with Triple-Negative Breast Cancer and Germline BRCA Mutation Undergoing Neoadjuvant Treatment Following the Keynote 522 Protocol
2025 · Monique Tavares, Flavia Cavalcanti Balint, et al. · Clinical Cancer Research
Analysis of risk factors for recurrence within 12 months after surgery in patients with breast cancer receiving neoadjuvant therapy at a Brazilian cancer center.
2024 · Guilherme Rossato de Almeida, Marcelle Goldner Cesca, et al. · Journal of Clinical Oncology
Abstract PO3-03-06: Real-world efficacy and safety of neoadjuvant pembrolizumab plus chemotherapy in Brazilian patients with early-stage triple-negative breast cancer
2024 · isadora sousa, Ana Carolina M. Comini, et al. · Cancer Research
Works count: 9
Citation count: 2
H-index: 1
I10-index:
Year
Topic
Type